These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31102266)

  • 1. Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.
    Barbieri JS; Gelfand JM
    Br J Dermatol; 2019 Nov; 181(5):1088-1090. PubMed ID: 31102266
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
    Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
    JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the DLQI appropriate for medical decision-making in psoriasis patients?
    Poór AK; Brodszky V; Péntek M; Gulácsi L; Ruzsa G; Hidvégi B; Holló P; Kárpáti S; Sárdy M; Rencz F
    Arch Dermatol Res; 2018 Jan; 310(1):47-55. PubMed ID: 29128966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations.
    Barbieri JS; Gelfand JM
    Br J Dermatol; 2019 Apr; 180(4):939-940. PubMed ID: 30430547
    [No Abstract]   [Full Text] [Related]  

  • 5. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
    Langenbruch A; Radtke MA; Gutknecht M; Augustin M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics.
    Mørk C; Wahl A; Moum T
    Acta Derm Venereol; 2002; 82(5):347-51. PubMed ID: 12430733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
    Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
    Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.
    Rencz F; Gulácsi L; Péntek M; Szegedi A; Remenyik É; Bata-Csörgő Z; Bali G; Hidvégi B; Tamási B; Poór AK; Hajdu K; Holló P; Kinyó Á; Sárdy M; Brodszky V
    Br J Dermatol; 2020 May; 182(5):1167-1175. PubMed ID: 31419310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis.
    Maul JT; Maul LV; Didaskalu JA; Valenzuela F; Romiti R; Peterson H; Korouri E; Novoa F; Oon HH; Zheng M; Wu JJ; Thyssen JP; Egeberg A; Armstrong AW; Nielsen ML
    Acta Derm Venereol; 2024 Mar; 104():adv20329. PubMed ID: 38470165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States.
    Barbieri JS; Gelfand JM
    JAMA Dermatol; 2019 Jun; 155(6):743-745. PubMed ID: 30969312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.
    Hjalte F; Carlsson KS; Schmitt-Egenolf M
    Br J Dermatol; 2018 Jan; 178(1):245-252. PubMed ID: 28644904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding happiness to complement the Dermatology Quality of Life Index in psoriasis and atopic dermatitis healthcare: a cross-sectional study.
    Schuster B; Ziehfreund S; Schielein MC; Tizek L; Biedermann T; Peifer C; Zink A
    Eur J Dermatol; 2022 Apr; 32(2):220-226. PubMed ID: 35866912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL; Corey KC; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of patients with plaque psoriasis who have discordance between Psoriasis Area Severity Index and dermatology life quality index scores.
    Amy de la Breteque M; Beauchet A; Quiles-Tsimaratos N; Estève E; Le Guyadec T; Ruer-Mulard M; Maccari F; Reguiai Z; Girard C; Bastien M; Avenel-Audran M; Pauwels C; Bouilly-Auvray D; Sigal ML; Mahé E;
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e269-e272. PubMed ID: 27785848
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients.
    Nijsten T; Meads DM; de Korte J; Sampogna F; Gelfand JM; Ongenae K; Evers AW; Augustin M
    J Invest Dermatol; 2007 Oct; 127(10):2315-22. PubMed ID: 17495953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.
    Gulliver W; Lynde C; Dutz JP; Vender RB; Yeung J; Bourcier M; Dion PL; Hong CH; Searles G; Poulin Y
    J Cutan Med Surg; 2015; 19(1):22-7. PubMed ID: 25775659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.